Works by Ikeda, Masafumi

Results: 230
    1

    Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113 Open Access.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 6, p. 594, doi. 10.1093/jjco/hyaf035
    By:
    • Okada, Mao;
    • Suzuki, Eiichiro;
    • Morizane, Chigusa;
    • Ogawa, Gakuto;
    • Sano, Yusuke;
    • Imaoka, Hiroshi;
    • Kobayashi, Satoshi;
    • Ikeda, Masafumi;
    • Okano, Naohiro;
    • Miwa, Haruo;
    • Todaka, Akiko;
    • Shimizu, Satoshi;
    • Mizuno, Nobumasa;
    • Satoi, Sohei;
    • Sano, Keiji;
    • Tobimatsu, Kazutoshi;
    • Katanuma, Akio;
    • Masutomi, Kenkichi;
    • Okusaka, Takuji;
    • Ozaka, Masato
    Publication type:
    Article
    2
    3

    Spontaneous regression of hepatocellular carcinoma.

    Published in:
    International Journal of Clinical Oncology, 2006, v. 11, n. 5, p. 407, doi. 10.1007/s10147-006-0591-4
    By:
    • Kondo, Shunsuke;
    • Okusaka, Takuji;
    • Ueno, Hideki;
    • Ikeda, Masafumi;
    • Morizane, Chigusa
    Publication type:
    Article
    4

    Characteristic Pattern of Reactivation of Hepatitis B Virus during Chemotherapy for Solid Cancers.

    Published in:
    Digestive Diseases, 2012, v. 30, n. 6, p. 541, doi. 10.1159/000343056
    By:
    • Hagiwara, Satoru;
    • Sakurai, Toshiharu;
    • Nishina, Shinichi;
    • Tanaka, Kaoru;
    • Ikeda, Masafumi;
    • Ueshima, Kazuomi;
    • Minami, Yasunori;
    • lnoue, Tatsuo;
    • Yada, Norihisa;
    • Kitai, Satoshi;
    • Takita, Masahiro;
    • Nagai, Tomoyuki;
    • Hayaishi, Sousuke;
    • Arizumi, Tadaaki;
    • Park, Ah-Mee;
    • Munakata, Hiroshi;
    • Nishida, Naoshi;
    • Kudo, Masatoshi
    Publication type:
    Article
    5
    6
    7

    Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31383-9
    By:
    • Takahashi, Daigoro;
    • Kojima, Motohiro;
    • Suzuki, Toshihiro;
    • Sugimoto, Motokazu;
    • Kobayashi, Shin;
    • Takahashi, Shinichiro;
    • Konishi, Masaru;
    • Gotohda, Naoto;
    • Ikeda, Masafumi;
    • Nakatsura, Tetsuya;
    • Ochiai, Atsushi;
    • Nagino, Masato
    Publication type:
    Article
    8
    9
    10
    11
    12

    Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.

    Published in:
    Journal of Gastroenterology, 2015, v. 50, n. 6, p. 667, doi. 10.1007/s00535-014-0996-1
    By:
    • Okita, Kiwamu;
    • Izumi, Namiki;
    • Ikeda, Kenji;
    • Osaki, Yukio;
    • Numata, Kazushi;
    • Ikeda, Masafumi;
    • Kokudo, Norihiro;
    • Imanaka, Kazuho;
    • Nishiguchi, Shuhei;
    • Kondo, Shunsuke;
    • Nishigaki, Yoichi;
    • Shiomi, Susumu;
    • Ueshima, Kazuomi;
    • Isoda, Norio;
    • Karino, Yoshiyasu;
    • Kudo, Masatoshi;
    • Tanaka, Katsuaki;
    • Kaneko, Shuichi;
    • Moriwaki, Hisataka;
    • Makuuchi, Masatoshi
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 4, p. 355, doi. 10.1093/jjco/hyae188
    By:
    • Fukushi, Koh;
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Mizusawa, Junki;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Kobayashi, Satoshi;
    • Sasahira, Naoki;
    • Shimizu, Satoshi;
    • Yamazaki, Kentaro;
    • Okano, Naohiro;
    • Miwa, Haruo;
    • Hara, Kazuo;
    • Satoi, Sohei;
    • Sano, Keiji;
    • Sakai, Kenji;
    • Sugimoto, Rie;
    • Nakamura, Kazuyoshi;
    • Terashima, Takeshi;
    • Ozaka, Masato
    Publication type:
    Article
    19
    20

    Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–22.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 10, p. 1071, doi. 10.1093/jjco/hyae048
    By:
    • Imaoka, Hiroshi;
    • Sasaki, Keita;
    • Machida, Ryunosuke;
    • Nagano, Hiroaki;
    • Satoi, Sohei;
    • Ikeda, Masafumi;
    • Kobayashi, Satoshi;
    • Yamashita, Taro;
    • Okusaka, Takuji;
    • Ido, Akio;
    • Hatano, Etsuro;
    • Miwa, Haruo;
    • Ueno, Masaki;
    • Nakao, Kazuhiko;
    • Shimizu, Satoshi;
    • Kuramochi, Hidekazu;
    • Sakamori, Ryotaro;
    • Tsumura, Hidetaka;
    • Okano, Naohiro;
    • Shioji, Kazuhiko
    Publication type:
    Article
    21
    22

    Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 764, doi. 10.1093/jjco/hyad062
    By:
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Umemoto, Kumiko;
    • Sunakawa, Yu;
    • Ueno, Makoto;
    • Ueno, Hideki;
    • Ozaka, Masato;
    • Kuwahara, Takamichi;
    • Okano, Naohiro;
    • Kanai, Masashi;
    • Hisano, Terumasa;
    • Suzuki, Yuko;
    • Asagi, Akinori;
    • Shioji, Kazuhiko;
    • Todaka, Akiko;
    • Tsuji, Kunihiro;
    • Ikezawa, Kenji;
    • Miki, Ikuya;
    • Komatsu, Yoshito;
    • Akutsu, Noriyuki
    Publication type:
    Article
    23

    Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 8, p. 704, doi. 10.1093/jjco/hyad044
    By:
    • Mizuno, Nobumasa;
    • Ioka, Tatsuya;
    • Ogawa, Gakuto;
    • Nakamura, Satoaki;
    • Hiraoka, Nobuyoshi;
    • Ito, Yoshinori;
    • Katayama, Hiroshi;
    • Takada, Ryoji;
    • Kobayashi, Satoshi;
    • Ikeda, Masafumi;
    • Miwa, Haruo;
    • Okano, Naohiro;
    • Kuramochi, Hidekazu;
    • Sekimoto, Mitsugu;
    • Okusaka, Takuji;
    • Ozaka, Masato;
    • Todaka, Akiko;
    • Gotoh, Kunihito;
    • Tobimatsu, Kazutoshi;
    • Yamaguchi, Hironori
    Publication type:
    Article
    24
    25

    Protocol of a randomized phase II/III study of gemcitabine plus nab-paclitaxel combination therapy versus modified FOLFIRINOX versus S-IROX for metastatic or recurrent pancreatic cancer: JCOG1611 (GENERATE).

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 80, doi. 10.1093/jjco/hyac146
    By:
    • Mizusawa, Junki;
    • Ohba, Akihiro;
    • Ozaka, Masato;
    • Katayama, Hiroshi;
    • Okusaka, Takuji;
    • Kobayashi, Satoshi;
    • Ikeda, Masafumi;
    • Terashima, Takeshi;
    • Sasahira, Naoki;
    • Okano, Naohiro;
    • Miki, Ikuya;
    • Kaneko, Takashi;
    • Mizuno, Nobumasa;
    • Todaka, Akiko;
    • Furukawa, Masayuki;
    • Kajiura, Shinya;
    • Kataoka, Tomoko;
    • Fukuda, Haruhiko;
    • Furuse, Junji;
    • Ueno, Makoto
    Publication type:
    Article
    26
    27
    28
    29

    Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 235, doi. 10.1093/jjco/hyaa198
    By:
    • Ioka, Tatsuya;
    • Furuse, Junji;
    • Fukutomi, Akira;
    • Mizusawa, Junki;
    • Nakamura, Satoaki;
    • Hiraoka, Nobuyoshi;
    • Ito, Yoshinori;
    • Katayama, Hiroshi;
    • Ueno, Makoto;
    • Ikeda, Masafumi;
    • Sugimori, Kazuya;
    • Okano, Naohiro;
    • Shimizu, Kyoko;
    • Yanagimoto, Hiroaki;
    • Okusaka, Takuji;
    • Ozaka, Masato;
    • Todaka, Akiko;
    • Nakamori, Shoji;
    • Tobimatsu, Kazutoshi;
    • Sata, Naohiro
    Publication type:
    Article
    30
    31

    5‐Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S‐1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1).

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2024, v. 31, n. 12, p. 886, doi. 10.1002/jhbp.12071
    By:
    • Mitsunaga, Shuichi;
    • Ikeda, Masafumi;
    • Nomura, Shogo;
    • Morizane, Chigusa;
    • Todaka, Akiko;
    • Yamamoto, Naoto;
    • Kamata, Ken;
    • Yanagibashi, Hiroo;
    • Mizuno, Nobumasa;
    • Kawamoto, Yasuyuki;
    • Gotoh, Kunihito;
    • Shirakawa, Hirofumi;
    • Okano, Naohiro;
    • Nomura, Tatsuya;
    • Tanaka, Kazunari;
    • Takahashi, Amane;
    • Yagi, Shintaro;
    • Ohta, Koji;
    • Takayama, Yukiko;
    • Miwa, Haruo
    Publication type:
    Article
    32

    Nivolumab for treating patients with occupational cholangiocarcinoma.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2022, v. 29, n. 11, p. 1153, doi. 10.1002/jhbp.1215
    By:
    • Tanaka, Shogo;
    • Umemoto, Kumiko;
    • Kubo, Shoji;
    • Sato, Yasunori;
    • Mimaki, Sachiyo;
    • Tsuchihara, Katsuya;
    • Takemura, Shigekazu;
    • Shinkawa, Hiroji;
    • Mori, Akira;
    • Ikeda, Masafumi
    Publication type:
    Article
    33
    34

    Cytotoxic chemotherapy for pancreatic neuroendocrine tumors.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2015, v. 22, n. 8, p. 628, doi. 10.1002/jhbp.257
    By:
    • Okusaka, Takuji;
    • Ueno, Hideki;
    • Morizane, Chigusa;
    • Kondo, Shunsuke;
    • Sakamoto, Yasunari;
    • Takahashi, Hideaki;
    • Ohno, Izumi;
    • Shimizu, Satoshi;
    • Mitsunaga, Shuichi;
    • Ikeda, Masafumi
    Publication type:
    Article
    35
    36
    37
    38
    39

    Impaired mental health among the bereaved spouses of cancer patients.

    Published in:
    Psycho-Oncology, 2013, v. 22, n. 5, p. 995, doi. 10.1002/pon.3090
    By:
    • Asai, Mariko;
    • Akizuki, Nobuya;
    • Fujimori, Maiko;
    • Shimizu, Ken;
    • Ogawa, Asao;
    • Matsui, Yutaka;
    • Akechi, Tatsuo;
    • Itoh, Kuniaki;
    • Ikeda, Masafumi;
    • Hayashi, Ryuichi;
    • Kinoshita, Taira;
    • Ohtsu, Atsushi;
    • Nagai, Kanji;
    • Kinoshita, Hiroya;
    • Uchitomi, Yosuke
    Publication type:
    Article
    40
    41

    The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04550-8
    By:
    • Yamada, Ikuhiro;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Mizusawa, Junki;
    • Kataoka, Tomoko;
    • Ueno, Makoto;
    • Ikeda, Masafumi;
    • Okano, Naohiro;
    • Todaka, Akiko;
    • Shimizu, Satoshi;
    • Mizuno, Nobumasa;
    • Sekimoto, Mitsugu;
    • Tobimatsu, Kazutoshi;
    • Yamaguchi, Hironori;
    • Nishina, Tomohiro;
    • Shirakawa, Hirofumi;
    • Kojima, Yasushi;
    • Oono, Takamasa;
    • Kawamoto, Yasuyuki;
    • Furukawa, Masayuki
    Publication type:
    Article
    42

    Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92166-3
    By:
    • Ueno, Makoto;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Mizusawa, Junki;
    • Kataoka, Tomoko;
    • Ikeda, Masafumi;
    • Ozaka, Masato;
    • Okano, Naohiro;
    • Sugimori, Kazuya;
    • Todaka, Akiko;
    • Shimizu, Satoshi;
    • Mizuno, Nobumasa;
    • Yamamoto, Tomohisa;
    • Sano, Keiji;
    • Tobimatsu, Kazutoshi;
    • Katanuma, Akio;
    • Miyamoto, Atsushi;
    • Yamaguchi, Hironori;
    • Nishina, Tomohiro;
    • Shirakawa, Hirofumi
    Publication type:
    Article
    43

    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer.

    Published in:
    BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03849-x
    By:
    • Mitsunaga, Shuichi;
    • Ikeda, Masafumi;
    • Ueno, Makoto;
    • Kobayashi, Satoshi;
    • Tsuda, Masahiro;
    • Miki, Ikuya;
    • Kuwahara, Takamichi;
    • Hara, Kazuo;
    • Takayama, Yukiko;
    • Matsunaga, Yutaro;
    • Hanada, Keiji;
    • Shimizu, Akinori;
    • Yoshida, Hitoshi;
    • Nomoto, Tomohiro;
    • Takahashi, Kenji;
    • Iwamoto, Hidetaka;
    • Iwama, Hideaki;
    • Hatano, Etsuro;
    • Nakata, Kohei;
    • Nakamura, Masafumi
    Publication type:
    Article
    44
    45

    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer.

    Published in:
    BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04079-x
    By:
    • Mitsunaga, Shuichi;
    • Ikeda, Masafumi;
    • Ueno, Makoto;
    • Kobayashi, Satoshi;
    • Tsuda, Masahiro;
    • Miki, Ikuya;
    • Kuwahara, Takamichi;
    • Hara, Kazuo;
    • Takayama, Yukiko;
    • Matsunaga, Yutaro;
    • Hanada, Keiji;
    • Shimizu, Akinori;
    • Yoshida, Hitoshi;
    • Nomoto, Tomohiro;
    • Takahashi, Kenji;
    • Iwamoto, Hidetaka;
    • Iwama, Hideaki;
    • Hatano, Etsuro;
    • Nakata, Kohei;
    • Nakamura, Masafumi
    Publication type:
    Article
    46

    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer.

    Published in:
    BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03849-x
    By:
    • Mitsunaga, Shuichi;
    • Ikeda, Masafumi;
    • Ueno, Makoto;
    • Kobayshi, Satoshi;
    • Tsuda, Masahiro;
    • Miki, Ikuya;
    • Kuwahara, Takamichi;
    • Hara, Kazuo;
    • Takayama, Yukiko;
    • Matsunaga, Yutaro;
    • Hanada, Keiji;
    • Shimizu, Akinori;
    • Yoshida, Hitoshi;
    • Nomoto, Tomohiro;
    • Takahashi, Kenji;
    • Iwamoto, Hidetaka;
    • Iwama, Hideaki;
    • Hatano, Etsuro;
    • Nakata, Kohei;
    • Nakamura, Masafumi
    Publication type:
    Article
    47

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13648-5
    By:
    • Kodama, Yoshihisa;
    • Ueshima, Kazuomi;
    • Moriguchi, Michihisa;
    • Inaba, Yoshitaka;
    • Yamashita, Tatsuya;
    • Iwamoto, Hideki;
    • Ueno, Makoto;
    • Ogasawara, Sadahisa;
    • Kuzuya, Teiji;
    • Kodama, Takahiro;
    • Sato, Yozo;
    • Tada, Toshifumi;
    • Tsuchiya, Kaoru;
    • Nishiofuku, Hideyuki;
    • Yamakado, Koichiro;
    • Sone, Miyuki;
    • Ikeda, Masafumi;
    • Takehara, Tetsuo;
    • Hamano, Tetsutaro;
    • Kudo, Masatoshi
    Publication type:
    Article
    48

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13648-5
    By:
    • Kodama, Yoshihisa;
    • Ueshima, Kazuomi;
    • Moriguchi, Michihisa;
    • Inaba, Yoshitaka;
    • Yamashita, Tatsuya;
    • Iwamoto, Hideki;
    • Ueno, Makoto;
    • Ogasawara, Sadahisa;
    • Kuzuya, Teiji;
    • Kodama, Takahiro;
    • Sato, Yozo;
    • Tada, Toshifumi;
    • Tsuchiya, Kaoru;
    • Nishiofuku, Hideyuki;
    • Yamakado, Koichiro;
    • Sone, Miyuki;
    • Ikeda, Masafumi;
    • Takehara, Tetsuo;
    • Hamano, Tetsutaro;
    • Kudo, Masatoshi
    Publication type:
    Article
    49
    50